nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abbreviations and Acronyms
|
|
|
2013 |
|
3 |
p. x- 1 p. |
artikel |
2 |
Abstract
|
|
|
2013 |
|
3 |
p. 262- 1 p. |
artikel |
3 |
Acknowledgments
|
|
|
2013 |
|
3 |
p. 302- 1 p. |
artikel |
4 |
Biographic and disclosure information
|
|
|
2013 |
|
3 |
p. 297-301 5 p. |
artikel |
5 |
Biology of stem cells: an overview
|
Chagastelles, Pedro C. |
|
2011 |
|
3 |
p. 63-67 5 p. |
artikel |
6 |
Cardiac and renal cell therapies: similarities and differences
|
Takiya, Christina M. |
|
2011 |
|
3 |
p. 99-102 4 p. |
artikel |
7 |
Changing the paradigms for the treatment of chronic kidney disease
|
Coyne, Daniel W. |
|
2017 |
|
3 |
p. 155-156 2 p. |
artikel |
8 |
Chapter 1: Assessment of lipid status in adults with CKD
|
|
|
2013 |
|
3 |
p. 268-270 3 p. |
artikel |
9 |
Chapter 3: Assessment of lipid status in children with CKD
|
|
|
2013 |
|
3 |
p. 280-281 2 p. |
artikel |
10 |
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
|
|
|
2013 |
|
3 |
p. 271-279 9 p. |
artikel |
11 |
Chapter 4: Pharmacological cholesterol-lowering treatment in children
|
|
|
2013 |
|
3 |
p. 282-283 2 p. |
artikel |
12 |
Chapter 5: Triglyceride-lowering treatment in adults
|
|
|
2013 |
|
3 |
p. 284-285 2 p. |
artikel |
13 |
Chapter 6: Triglyceride-lowering treatment in children
|
|
|
2013 |
|
3 |
p. 286- 1 p. |
artikel |
14 |
Conversion factors of Conventional units to SI units
|
|
|
2013 |
|
3 |
p. ix- 1 p. |
artikel |
15 |
Current Chronic Kidney Disease (CKD) Nomenclature used by Kdigo
|
|
|
2013 |
|
3 |
p. viii- 1 p. |
artikel |
16 |
Editorial Board
|
|
|
2018 |
|
3 |
p. A1 |
artikel |
17 |
Editorial Board
|
|
|
2017 |
|
3 |
p. A1- 1 p. |
artikel |
18 |
Foreword
|
|
|
2013 |
|
3 |
p. 260- 1 p. |
artikel |
19 |
Genetic tracing of the epithelial lineage during mammalian kidney repair
|
Humphreys, Benjamin D. |
|
2011 |
|
3 |
p. 83-86 4 p. |
artikel |
20 |
Introduction: The case for updating and context
|
|
|
2013 |
|
3 |
p. 266-267 2 p. |
artikel |
21 |
KDIGO Board Members
|
|
|
2013 |
|
3 |
p. vi- 1 p. |
artikel |
22 |
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
|
|
|
2018 |
|
3 |
p. 91-165 |
artikel |
23 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59
|
|
|
2017 |
|
3 |
p. e1- 1 p. |
artikel |
24 |
Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks
|
Kunter, Uta |
|
2011 |
|
3 |
p. 68-73 6 p. |
artikel |
25 |
Mesenchymal stromal cells: main factor or helper in regenerative medicine?
|
Zander, Axel R. |
|
2011 |
|
3 |
p. 74-76 3 p. |
artikel |
26 |
Methods for guideline development
|
|
|
2013 |
|
3 |
p. 287-296 10 p. |
artikel |
27 |
New options for the anemia of chronic kidney disease
|
Coyne, Daniel W. |
|
2017 |
|
3 |
p. 157-163 7 p. |
artikel |
28 |
New options for the management of chronic hyperkalemia
|
Fried, Linda |
|
2017 |
|
3 |
p. 164-170 7 p. |
artikel |
29 |
Notice
|
|
|
2013 |
|
3 |
p. 259- 1 p. |
artikel |
30 |
Potential of mesenchymal stem cells in the repair of tubular injury
|
Imberti, Barbara |
|
2011 |
|
3 |
p. 90-93 4 p. |
artikel |
31 |
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials
|
Westenfelder, Christof |
|
2011 |
|
3 |
p. 103-106 4 p. |
artikel |
32 |
Reference Keys
|
|
|
2013 |
|
3 |
p. vii- 1 p. |
artikel |
33 |
References
|
|
|
2013 |
|
3 |
p. 303-305 3 p. |
artikel |
34 |
Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury
|
Togel, Florian E. |
|
2011 |
|
3 |
p. 87-89 3 p. |
artikel |
35 |
Stem cell therapy for diabetes mellitus
|
Voltarelli, Júlio C. |
|
2011 |
|
3 |
p. 94-98 5 p. |
artikel |
36 |
Subscription Information
|
|
|
2018 |
|
3 |
p. A2 |
artikel |
37 |
Subscription Information
|
|
|
2017 |
|
3 |
p. A3- 1 p. |
artikel |
38 |
Summary of Recommendation Statements
|
|
|
2013 |
|
3 |
p. 263-265 3 p. |
artikel |
39 |
Table of Contents
|
|
|
2018 |
|
3 |
p. A3 |
artikel |
40 |
Table of Contents
|
|
|
2017 |
|
3 |
p. A7- 1 p. |
artikel |
41 |
Tables and Figures
|
|
|
2013 |
|
3 |
p. v- 1 p. |
artikel |
42 |
The potential use of stem cells derived from human amniotic fluid in renal diseases
|
Noronha, Irene L. |
|
2011 |
|
3 |
p. 77-82 6 p. |
artikel |
43 |
Title Page
|
|
|
2017 |
|
3 |
p. A5- 1 p. |
artikel |
44 |
Training nephrologists from developing countries: does it have a positive impact?
|
Harris, David C.H. |
|
2012 |
|
3 |
p. 275-278 4 p. |
artikel |
45 |
Work Group Membership
|
|
|
2013 |
|
3 |
p. 261- 1 p. |
artikel |